Together with 12 other European Regions, MedCoast is participating in the 7th European Framework Programme (FP7) project TERM - Tissue Engineering Regenerative Medicine. The main objective is strengthening the transnational cooperation between regional research clusters in the field of TERM by establishing a European model network for the development of world-class clusters.
Full name: Linking research organisations in the fields of Tissue Engineering and Regenerative Medicine through European cooperation between regional research clusters
Budget: €2 795 041
MedCoast budget: €289,080.00
Project period: 36 months from 1 October 2010 to 30 September 2013
Lead partner: Atlanpole Biothérapies, France
Consortium: MedCoast has formed a third party consortium with GöteborgBIO/Business Region Göteborg and Göteborg University to perform the work in TERM.
Key objectives:
- Assessing the capacity of European regions in contributing to the development of Advanced Therapies through their regional research policy
- Organising coherent and structured regional and European support to TERM research & networks
- Developing a European knowledge of available skills and infrastructures through dedicated tools
- Setting up a financial plan to enable the implementation of the TERM action plan and provide recommendations for the next financial instruments to policy-makers
- Broadly disseminating the project outcomes and enabling the TERM initiative to grow, to be sustainable after the end of the project and giving birth to a World-Class Cluster
Partners:
View TERM in a larger map
1) Atlanpole Biothérapies (FR)
2) MedCoast Scandinavia (NO/SE)
3) Fondazione Centro San Raffaele del Monte Tabor (IT)
4) UppsalaBIO (SE)
5) Biowin (BE)
6) Madrid BioCluster (ES)
7) Baltic Innovation Agency (EE)
8) Berlin – Brandenburg Center for Regenerative Therapies (DE)
9) Interface Europe (BE)
10) Région Pays de la Loire (FR)
11) Service public de Wallonie (BE)
12) Vinnova (SE)
13) Uppsala Regional Council (SE)
Fact sheet about TERM >>
Please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it in MedCoast for more information.
..............................................................................................................................................................................
